SitesBLAST
Comparing GFF3560 PGA1_c36140 D-3-phosphoglycerate dehydrogenase SerA to proteins with known functional sites using BLASTp with E ≤ 0.001.
Or try Sites on a Tree, PaperBLAST, Conserved Domains, or compare to all protein structures
Found 20 (the maximum) hits to proteins with known functional sites (download)
3dc2A Crystal structure of serine bound d-3-phosphoglycerate dehydrogenase from mycobacterium tuberculosis (see paper)
40% identity, 97% coverage: 3:515/531 of query aligns to 2:512/526 of 3dc2A
- active site: N96 (= N100), R230 (= R234), D254 (= D258), E259 (= E263), H277 (= H281)
- binding serine: Y458 (≠ N461), D460 (= D463), R461 (≠ V464), P462 (= P465), G463 (= G466), A464 (≠ I467), L465 (≠ I468), L484 (= L487)
3ddnB Crystal structure of hydroxypyruvic acid phosphate bound d-3- phosphoglycerate dehydrogenase in mycobacterium tuberculosis (see paper)
40% identity, 97% coverage: 3:515/531 of query aligns to 3:511/525 of 3ddnB
- active site: N97 (= N100), R231 (= R234), D255 (= D258), E260 (= E263), H278 (= H281)
- binding 2-oxo-3-(phosphonooxy)propanoic acid: R49 (= R52), S50 (= S53), R70 (= R73), G72 (= G75), V73 (≠ I76), G74 (= G77), N97 (= N100), A281 (= A284), Q287 (= Q290)
O43175 D-3-phosphoglycerate dehydrogenase; 3-PGDH; 2-oxoglutarate reductase; Malate dehydrogenase; EC 1.1.1.95; EC 1.1.1.399; EC 1.1.1.37 from Homo sapiens (Human) (see 3 papers)
39% identity, 77% coverage: 4:414/531 of query aligns to 8:418/533 of O43175
- T78 (≠ I76) binding
- R135 (≠ K133) to W: in PHGDHD; results in a 2-fold decrease in enzyme activity with 3-phosphohydroxypyruvate, but no change in substrate affinity; dbSNP:rs267606949
- RI 155:156 (≠ NI 153:154) binding
- D175 (= D173) binding
- T207 (≠ V205) binding
- CAR 234:236 (= CAR 232:234) binding
- D260 (= D258) binding
- V261 (= V259) to M: in PHGDHD; results in a four-fold decrease in substrate affinity and a slight increase in maximal enzyme activity with 3-phosphohydroxypyruvate; dbSNP:rs267606947
- HLGA 283:286 (= HLGA 281:284) binding
- A373 (≠ S371) to T: in PHGDHD; results in almost undetectable enzyme activity with 3-phosphohydroxypyruvate; dbSNP:rs201553627
- G377 (= G375) to S: in PHGDHD; results in a 2-fold decrease in enzyme activity with 3-phosphohydroxypyruvate, but no change in substrate affinity; dbSNP:rs267606948
Sites not aligning to the query:
- 1 modified: Initiator methionine, Removed
- 2 modified: N-acetylalanine
- 425 V → M: in PHGDHD; results in almost undetectable enzyme activity with 3-phosphohydroxypyruvate; dbSNP:rs121907988
- 490 V → M: in PHGDHD; results in almost undetectable enzyme activity with 3-phosphohydroxypyruvate; dbSNP:rs121907987
7ewhA Crystal structure of human phgdh in complex with homoharringtonine
47% identity, 56% coverage: 4:301/531 of query aligns to 3:298/302 of 7ewhA
- binding (3beta)-O~3~-[(2R)-2,6-dihydroxy-2-(2-methoxy-2-oxoethyl)-6-methylheptanoyl]cephalotaxine: I145 (≠ V148), L146 (≠ I149), G147 (= G150), L148 (≠ A151), G149 (= G152), R150 (≠ N153), I151 (= I154), G152 (= G155), D170 (= D173), P171 (= P174), I172 (≠ F175), V200 (≠ L203), H201 (= H204), T202 (≠ V205), P203 (= P206)
6rihA Crystal structure of phgdh in complex with compound 9 (see paper)
47% identity, 56% coverage: 4:301/531 of query aligns to 3:298/302 of 6rihA
- binding ~{N}-cyclopropyl-2-methyl-5-phenyl-pyrazole-3-carboxamide: L146 (≠ I149), G147 (= G150), G149 (= G152), Y169 (= Y172), D170 (= D173), P171 (= P174), I172 (≠ F175), I173 (≠ L176), L188 (= L191), T202 (≠ V205), P203 (= P206), T208 (= T211), L211 (≠ I214)
6cwaA Crystal structure phgdh in complex with nadh and 3-phosphoglycerate at 1.77 a resolution (see paper)
47% identity, 56% coverage: 4:301/531 of query aligns to 2:297/299 of 6cwaA
- binding 1,4-dihydronicotinamide adenine dinucleotide: T72 (≠ I76), N96 (= N100), A100 (≠ T104), G146 (= G150), G148 (= G152), R149 (≠ N153), I150 (= I154), Y168 (= Y172), D169 (= D173), P170 (= P174), I171 (≠ F175), H200 (= H204), T201 (≠ V205), P202 (= P206), S206 (≠ Q210), T207 (= T211), C228 (= C232), A229 (= A233), R230 (= R234), D254 (= D258), H277 (= H281), G279 (= G283), A280 (= A284)
6rj5A Crystal structure of phgdh in complex with compound 39 (see paper)
47% identity, 56% coverage: 4:301/531 of query aligns to 3:298/301 of 6rj5A
- binding 2-methyl-~{N}-[(1~{R})-1-[4-(methylsulfonylcarbamoyl)phenyl]ethyl]-5-phenyl-pyrazole-3-carboxamide: T73 (≠ I76), P94 (= P97), L146 (≠ I149), G147 (= G150), G149 (= G152), I151 (= I154), Y169 (= Y172), D170 (= D173), P171 (= P174), I172 (≠ F175), I173 (≠ L176), L188 (= L191), H201 (= H204), T202 (≠ V205), P203 (= P206), T208 (= T211), L211 (≠ I214)
7dkmA Phgdh covalently linked to oridonin (see paper)
47% identity, 56% coverage: 4:301/531 of query aligns to 4:299/306 of 7dkmA
- binding nicotinamide-adenine-dinucleotide: T74 (≠ I76), N98 (= N100), A102 (≠ T104), L147 (≠ I149), G148 (= G150), G150 (= G152), R151 (≠ N153), I152 (= I154), Y170 (= Y172), D171 (= D173), P172 (= P174), I173 (≠ F175), H202 (= H204), T203 (≠ V205), P204 (= P206), S208 (≠ Q210), T209 (= T211), C230 (= C232), A231 (= A233), R232 (= R234), D256 (= D258), H279 (= H281), G281 (= G283), A282 (= A284)
- binding (1beta,6beta,7beta,8alpha,9beta,10alpha,13alpha,14R,16beta)-1,6,7,14-tetrahydroxy-7,20-epoxykauran-15-one: C14 (≠ A14), K17 (≠ Q17), I18 (= I18), D21 (= D21), E293 (≠ L295)
6plfA Crystal structure of human phgdh complexed with compound 1 (see paper)
47% identity, 56% coverage: 4:301/531 of query aligns to 4:299/305 of 6plfA
- binding 4-{(1S)-1-[(5-chloro-6-{[(5S)-2-oxo-1,3-oxazolidin-5-yl]methoxy}-1H-indole-2-carbonyl)amino]-2-hydroxyethyl}benzoic acid: G148 (= G150), G150 (= G152), Y170 (= Y172), D171 (= D173), P172 (= P174), I173 (≠ F175), I174 (≠ L176), L189 (= L191), H202 (= H204), T203 (≠ V205), P204 (= P206), S208 (≠ Q210), T209 (= T211), L212 (≠ I214)
6plgA Crystal structure of human phgdh complexed with compound 15 (see paper)
47% identity, 56% coverage: 4:301/531 of query aligns to 3:298/303 of 6plgA
- binding (2S)-(4-{3-[(4,5-dichloro-1-methyl-1H-indole-2-carbonyl)amino]oxetan-3-yl}phenyl)(pyridin-3-yl)acetic acid: L148 (≠ A151), G149 (= G152), R150 (≠ N153), I151 (= I154), Y169 (= Y172), D170 (= D173), P171 (= P174), I172 (≠ F175), I173 (≠ L176), H201 (= H204), T202 (≠ V205), P203 (= P206), L205 (≠ T208), S207 (≠ Q210), A230 (= A233), R231 (= R234)
6rj3A Crystal structure of phgdh in complex with compound 15 (see paper)
47% identity, 56% coverage: 4:301/531 of query aligns to 2:297/297 of 6rj3A
- binding 4-[(1~{R})-1-[(2-methyl-5-phenyl-pyrazol-3-yl)carbonylamino]ethyl]benzoic acid: L145 (≠ I149), G146 (= G150), G148 (= G152), Y168 (= Y172), D169 (= D173), P170 (= P174), I171 (≠ F175), I172 (≠ L176), L187 (= L191), H200 (= H204), T201 (≠ V205), P202 (= P206), T207 (= T211), L210 (≠ I214)
6rj2A Crystal structure of phgdh in complex with compound 40 (see paper)
47% identity, 56% coverage: 5:301/531 of query aligns to 1:295/299 of 6rj2A
- binding ~{N}-[(1~{R})-1-[4-(ethanoylsulfamoyl)phenyl]ethyl]-2-methyl-5-phenyl-pyrazole-3-carboxamide: L143 (≠ I149), G144 (= G150), G146 (= G152), R147 (≠ N153), I148 (= I154), Y166 (= Y172), D167 (= D173), P168 (= P174), I169 (≠ F175), I170 (≠ L176), H198 (= H204), T199 (≠ V205), P200 (= P206), T205 (= T211), L208 (≠ I214), R228 (= R234)
6plfB Crystal structure of human phgdh complexed with compound 1 (see paper)
46% identity, 56% coverage: 4:301/531 of query aligns to 2:289/292 of 6plfB